Common Side Effects and Monitoring
Cosentyx (secukinumab) treats conditions like psoriasis, psoriatic arthritis, and ankylosing spondylitis by blocking IL-17A. Patients often experience upper respiratory infections, diarrhea, or cold sores. Monitor for signs of infection like fever or cough, as it suppresses immune response—inactive tuberculosis screening is required before starting.[1][2]
Infection Risks and Prevention
This drug increases susceptibility to serious infections, including tuberculosis reactivation. Avoid live vaccines during treatment. Get tested for latent TB and hepatitis B beforehand. If an active infection develops, pause Cosentyx until resolved. Wash hands frequently and avoid sick contacts.[1][3]
Allergic Reactions to Watch For
Rare but severe allergic responses include angioedema, hives, or anaphylaxis. Stop use and seek emergency care for swelling, breathing difficulty, or rash. Infusion or injection-site reactions occur in some; rotate sites and report persistent pain or redness.[2][4]
Precautions for Specific Groups
Pregnant or breastfeeding patients: Limited data exists—use only if benefits outweigh risks, and consider registry enrollment. Not recommended for children under 6 with plaque psoriasis. Elderly patients may face higher infection risk; adjust based on health status. Avoid if history of inflammatory bowel disease, as it may worsen Crohn's.[1][3]
Drug Interactions and Vaccinations
Combining with other biologics, TNF blockers, or immunosuppressants raises infection risk—avoid unless advised. Update non-live vaccines before starting. CYP450 substrates like statins may need monitoring, as Cosentyx mildly affects liver enzymes.[2][4]
Before and During Use Steps
- Disclose full medical history, especially infections or cancer.
- Use clean technique for self-injections; store refrigerated.
- Regular blood tests for liver function and blood counts.
- Report new symptoms like persistent cough or weight loss promptly.
[1]: Cosentyx Prescribing Information, Novartis, https://www.cosentyx.com
[2]: FDA Label for Secukinumab, https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/125504s042lbl.pdf
[3]: Drugs.com - Cosentyx Precautions, https://www.drugs.com/cosentyx.html
[4]: Mayo Clinic - Secukinumab Side Effects, https://www.mayoclinic.org/drugs-supplements/secukinumab-subcutaneous-route/side-effects/drg-20164113